share_log

药明生物(02269.HK)获李革增持144.5万股普通股股份,价值约1,672.37万港元

Yao Ming Biotech (02269.HK) was granted by Li Ge to increase its common stock holdings by 1,445 million shares, worth approximately HK$16.723,700

Futu News ·  Jun 25 17:04

According to the documents disclosed by the Hong Kong Stock Exchange on June 25, Li Ge increased his shareholding on June 24 at an average price of HK$11.5735 per share, purchasing 1.445 million ordinary shares worth approximately HK$16.7237 million. After the increase, Li Ge's latest holding is 593 million shares, and the good warehouse ratio has risen from 14.24% to 14.28%.$WUXI BIO (02269.HK)$Supplementary information: Box 33: Mr. Zhaohui Zhang and Mr. Xiaozhong Liu continue to be considered parties in relation to the 592,902,633 shares of the Company.

What is equity disclosure?

According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the company's shares) must disclose their shareholding in the listed company. Directors and senior executives of the listed company must disclose their shareholding and equity certificate rights in the listed company and any related companies.

Why is equity disclosure important?

Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment